Cefotaxime
Back to searchMolecule Structure
Scientific Name
Cefotaxime
Description of the Drug
Cefotaxime is a third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00493
http://www.drugbank.ca/drugs/DB00493
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Cephazone Pharma Llc, Hospira Inc, Validus Pharmaceuticals Llc, Aurobindo Pharma Ltd, Wockhardt Ltd, B Braun Medical Inc, Sanofi Aventis Us Llc, Lupin Ltd, Hikma Farmaceutica Lda
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3731931 | ||
| Human Metabolome Database | HMDB0014636 | ||
| DrugBank | DB00493 | ||
| PubChem: Thomson Pharma | 14808825 | 14857885 | |
| PubChem | 5742673 | ||
| Nikkaji | J18.743G | ||
| PDBe | CE3 | ||
| BindingDB | 50482777 | ||
| DrugCentral | 546 | ||
| ChemicalBook | CB6511698 | ||
| Guide to Pharmacology | 10893 | ||
| rxnorm | CLAFORAN | CEFOTAXIME SODIUM | CEFOTAXIME |
| KEGG Ligand | C06885 | ||
| ChEBI | 204928 | ||
| ZINC | ZINC000004468780 |
